NEW YORK (GenomeWeb News) – Mazama Capital Management owns a 10 percent stake in Affymetrix’s Class A common stock, according to a filing with the US Securities and Exchange Commission today.
 
The Portland, Oregon-based investment advisory firm owned 6,783,041 shares of Affy’s common stock as of April 15.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.